Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan) (RESCUE)

Pfizer

Status: Completed

Conditions: Pelvic Inflammatory Disease; Pneumonia

Treatments: Drug: Azithromycin IV

Study type: Observational

Funder types: Industry

Identifiers

NCT01671280

A0661207

Details and patient eligibility

About

To collect the efficacy and safety information of Azithromycin IV related to their appropriate use in daily practice

Enrollment: 403 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male or Female patients who are prescribed Zithromac IV for pneumonia or pelvic inflammatory disease.

Exclusion criteria

• Subjects who have been prescribed Zithromac IV for pneumonia or pelvic inflammatory disease.

Trial design

403 participants in 1 patient group

Azithromycin IV

Description:

Subjects who are treated with Azithromycin IV

Treatment:

Drug: Azithromycin IV